Midi Health Raises $100M in Series D Funding, Reaching $1 Billion Valuation

Some companies raise money. Others change the tempo. Midi Health just dropped a Series D that feels less like a victory lap and more like a bassline you feel in your chest. $100M raised, valuation north of $1B, and suddenly a conversation that spent decades whispering is now getting mic time. Not because it is trendy, but because it is overdue. Perimenopause and menopause were treated like background noise in healthcare. Midi Health turned the volume up and made it impossible to ignore.

Joanna Strober did not start this company because the market looked good on a spreadsheet. She started it because the system failed her personally, and then had the nerve to fail millions of other women the same way. Alongside Sharon Meers, Jill Herzig, Kathleen Jordan MD, and Mindy Goldman MD, she built something that sits at the intersection of lived experience and clinical rigor. That mix matters. It is why Midi Health feels human in an industry that often hides behind portals and policy codes.

The product is deceptively simple. Insurance covered, virtual care for women in midlife, available in all 50 states, delivered by clinicians who actually know this chapter of health. Under the hood, it is a different story. AI driven clinical decision support, data that reflects real women instead of clinical footnotes, and outcomes that move needles health systems care about. When 91% of patients report symptom improvement in 2 months and total cost of care drops by double digits, that is not marketing copy. That is leverage.

Goodwater Capital led this round, with Foresite Capital and Serena Ventures joining, and returning conviction from Advance Venture Partners, GV, Emerson Collective, SemperVirens, McKesson Ventures, and Felicis Ventures. Capital follows clarity. Investors did not back a buzzword. They backed execution, traction, and a model that scales without losing its soul.

The leadership bench reads like a quiet flex. Jaikumar Ramanathan bringing engineering discipline. Jason Wheeler stepping in as CFO with scar tissue from Tesla and Google. Melissa Waters shaping the voice after doing the same at Meta, hims and hers, and Lyft. Matt Cook building commercial pathways that actually respect providers and patients. This is not accidental growth. It is composed.

There is a reason the name works. A midi is not background Muzak and it is not noise for noise’s sake. It is the range where melody lives, where complexity becomes listenable, where you can build something people actually stay with. Midi Health is operating in that range now, between clinical depth and cultural relevance, between system change and individual relief, and the question is not whether this space gets bigger, it is who else is finally ready to hear what has been playing all along.